#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10626	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2099	501.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1712	1712	T	567	T,C	541,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10626	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2099	501.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1446	1446	C	626	C	606	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	10626	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2099	501.8	0	HET	.	.	.	C226T	.	226	226	C	488	488	C	588	C,T	430,137	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19758	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3521	557.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1732	1732	A	685	A,G	659,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19758	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3521	557.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2366	2366	C	600	C,A	578,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19758	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3521	557.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2440	2440	A	622	A	602	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	19758	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3521	557.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2992	2992	C	573	C,A	553,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1444	folP	855	855	99.88	folP.l15.c17.ctg.1	1541	93.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1015	1017	AGC	148;148;149	A;G;C	145;143;141	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4200	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3268	127.3	0	.	p	.	0	G95A	NONSYN	283	285	GGC	568	570	GCC	151;147;146	G;C;C	144;142;142	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	4200	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3268	127.3	1	SNP	p	S91F	1	.	.	271	273	TTC	556	558	TTC	146;146;149	T;T;C	140;141;144	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1154	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1339	85.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	422	424	ACC	130;128;127	A;C;C	125;126;123	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1154	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1339	85.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	620	622	CAC	140;140;139	C;A;C	132;133;134	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1154	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1339	85.5	0	.	p	.	0	A127fs	FSHIFT	379	379	G	686	686	G	121	GCCCC,GCC	116,1	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1154	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1339	85.5	1	SNP	p	G45D	0	.	.	133	135	GGC	440	442	GGC	132;134;136	G;G;C	131;132;135	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	696	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1008	68.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3580	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2874	123.5	0	.	p	.	0	S87N	NONSYN	259	261	AGT	577	579	AAT	151;153;153	A,C;A,G;T	145,2;147,2;150	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3580	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2874	123.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1621	1623	GCA	150;148;147	G;C,T;A	143;133,1;135	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3580	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2874	123.5	1	SNP	p	D86N	0	.	.	256	258	GAC	574	576	GAC	149;149;150	G;A;C	146;140;147	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3580	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2874	123.5	1	SNP	p	S88P	0	.	.	262	264	TCC	580	582	TCC	153;154;154	T;C;C	150;150;149	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2998	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2665	111.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1536	1538	GGC	165;165;166	G;G,T;C	162;158,2;163	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1289	1291	GCA	178;179;183	G,C;C;A	170,1;170;177	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1292	1294	ATC	182;183;183	A;T;C	173;173;173	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1304	1306	GTG	177;175;174	G;T;G	169;163;165	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1304	1306	GTG	177;175;174	G;T;G	169;163;165	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1808	1810	ACC	119;118;119	A;C;C	115;115;116	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1862	1864	GCG	125;123;127	G;C,G;G	113;103,1;117	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1862	1864	GCG	125;123;127	G;C,G;G	113;103,1;117	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1985	1987	GGT	125;125;125	G;G;T	123;121;120	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1994	1996	GGC	115;114;111	G;G;C	112;110;107	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2916	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2498	116.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2012	2014	CCG	87;89;91	C,G,T;C,G;G	73,3,1;77,1;85	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4360	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3136	138.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1645	1647	CCG	144;146;145	C;C;G	134;140;135	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1986	porA	1146	1146	99.65	porA.l6.c17.ctg.1	1698	115.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	497	497	C	151	C,G	141,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2048	porB1b	1035	1035	99.14	porB1b.l15.c4.ctg.1	1644	123.5	0	.	p	.	0	.	INDELS	629	630	AA	904	906	TAG	153;150;149	T;A;G	146;145;139	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2048	porB1b	1035	1035	99.14	porB1b.l15.c4.ctg.1	1644	123.5	0	.	p	.	0	.	MULTIPLE	631	633	TAC	908	911	CAAT	149;149;147;148	C;A;A;T,A	141;141;145;139,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2048	porB1b	1035	1035	99.14	porB1b.l15.c4.ctg.1	1644	123.5	0	.	p	.	0	N212fs	FSHIFT	634	634	A	913	913	T	146	T	140	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2048	porB1b	1035	1035	99.14	porB1b.l15.c4.ctg.1	1644	123.5	1	SNP	p	G120K	0	.	.	358	360	GGT	632	634	GGT	148;147;145	G;G;T,G,A	143;142;130,2,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2048	porB1b	1035	1035	99.14	porB1b.l15.c4.ctg.1	1644	123.5	1	SNP	p	A121D	0	.	.	361	363	GCC	635	637	GCC	146;142;146	G;C;C	143;139;145	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2048	porB1b	1035	1035	99.14	porB1b.l15.c4.ctg.1	1644	123.5	1	SNP	p	A121N	0	.	.	361	363	GCC	635	637	GCC	146;142;146	G;C;C	143;139;145	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	7304	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4762	152.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1943	1945	AAT	153;154;153	A;A;T	151;150;151	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	770	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	910	83.4	1	SNP	p	V57M	1	.	.	169	171	ATG	488	490	ATG	154;156;154	A;T;G	143;147;146	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	M177T	NONSYN	529	531	ATG	947	949	ACG	287;284;285	A;C,T;G	276;280,1;279	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	968	970	GAC	266;264;264	G;A,T;C	264;260,1;261	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	T190M	NONSYN	568	570	ACG	986	988	ATG	243;242;242	A;T;G	242;242;241	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	L194S	NONSYN	580	582	TTA	998	1000	TCA	229;228;227	T;C;A	227;227;227	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1043	1045	CAG	232;231;234	C;A;G	230;229;232	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1064	1066	CTT	214;211;206	C;T;T	212;211;205	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1085	1087	AGT	225;227;228	A;G;T,C,A	220;223;216,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1154	1156	CCG	285;287;290	C;C;G	275;278;276	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1256	1258	TCG	271;271;271	T;C;G,T	265;262;259,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1427	1429	AAA	174;175;178	A,G;A;A,G	168,1;171;172,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1430	1432	AAG	179;178;179	A;A,G;G,A	176;172,1;174,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1445	1447	CAC	163;163;163	C;A,C,T;C	162;158,2,1;161	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1484	1486	GAA	168;163;163	G;A;A	168;161;163	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1562	1564	ACG	121;117;114	A,G;C;G	120,1;115;113	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1613	1615	ATT	141;141;142	A;T,C;T	138;137,1;139	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1616	1618	AGT	143;141;140	A,T;G;T	138,1;138;134	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1655	1657	CTA	149;151;154	C;T;A	145;148;151	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1697	1699	AAT	114;114;113	A;A;T	112;112;112	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1766	1768	TCA	156;156;157	T;C;A	155;153;153	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1790	1792	ATG	176;178;179	A;T;G,A	175;176;176,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2084	2086	ACC	357;354;354	A,G;C;C	342,1;346;345	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6310	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2709	231.5	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2180	2182	GAA	357;352;350	G,T;A;A	348,1;346;345	.	Tetracycline resistance
